Literature DB >> 20306269

Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Thomas G Beach1, Charles H Adler, Lucia I Sue, Linda Vedders, Lihfen Lue, Charles L White Iii, Haru Akiyama, John N Caviness, Holly A Shill, Marwan N Sabbagh, Douglas G Walker.   

Abstract

A sensitive immunohistochemical method for phosphorylated alpha-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson's disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer's disease with Lewy bodies (ADLB) and 17 with Alzheimer's disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated alpha-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306269      PMCID: PMC2866090          DOI: 10.1007/s00401-010-0664-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  81 in total

1.  Lewy body pathology in long-term fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another?

Authors:  Jeffrey H Kordower; Patrik Brundin
Journal:  Neuropsychopharmacology       Date:  2009-01       Impact factor: 7.853

2.  Lewy body pathology involves cutaneous nerves.

Authors:  Masako Ikemura; Yuko Saito; Renpei Sengoku; Yoshio Sakiyama; Hiroyuki Hatsuta; Kazutomi Kanemaru; Motoji Sawabe; Tomio Arai; Genta Ito; Takeshi Iwatsubo; Masashi Fukayama; Shigeo Murayama
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

3.  Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.

Authors:  Thomas G Beach; Charles L White; Christa L Hladik; Marwan N Sabbagh; Donald J Connor; Holly A Shill; Lucia I Sue; Jeanne Sasse; Jyothi Bachalakuri; Jonette Henry-Watson; Haru Akiyama; Charles H Adler
Journal:  Acta Neuropathol       Date:  2008-11-04       Impact factor: 17.088

4.  Evaluation of alpha-synuclein immunohistochemical methods used by invited experts.

Authors:  Thomas G Beach; Charles L White; Ronald L Hamilton; John E Duda; Takeshi Iwatsubo; Dennis W Dickson; James B Leverenz; Federico Roncaroli; Manuel Buttini; Christa L Hladik; Lucia I Sue; Joseph V Noorigian; Charles H Adler
Journal:  Acta Neuropathol       Date:  2008-07-15       Impact factor: 17.088

5.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

6.  Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein.

Authors:  Paula Desplats; He-Jin Lee; Eun-Jin Bae; Christina Patrick; Edward Rockenstein; Leslie Crews; Brian Spencer; Eliezer Masliah; Seung-Jae Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

7.  Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.

Authors:  Karin M Danzer; Simon K Krebs; Michael Wolff; Gerald Birk; Bastian Hengerer
Journal:  J Neurochem       Date:  2009-08-04       Impact factor: 5.372

8.  Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group.

Authors:  Charles H Knowles; Roberto De Giorgio; Raj P Kapur; Elisabeth Bruder; Gianrico Farrugia; Karel Geboes; Michael D Gershon; John Hutson; Greger Lindberg; Joanne E Martin; William A Meier-Ruge; Peter J Milla; Virpi V Smith; Jean Marie Vandervinden; Béla Veress; Thilo Wedel
Journal:  Acta Neuropathol       Date:  2009-04-10       Impact factor: 17.088

9.  Transplanted dopaminergic neurons develop PD pathologic changes: a second case report.

Authors:  Jeffrey H Kordower; Yaping Chu; Robert A Hauser; C Warren Olanow; Thomas B Freeman
Journal:  Mov Disord       Date:  2008-12-15       Impact factor: 10.338

10.  The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007.

Authors:  Thomas G Beach; Lucia I Sue; Douglas G Walker; Alex E Roher; LihFen Lue; Linda Vedders; Donald J Connor; Marwan N Sabbagh; Joseph Rogers
Journal:  Cell Tissue Bank       Date:  2008-03-18       Impact factor: 1.522

View more
  292 in total

Review 1.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

2.  Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease.

Authors:  Anne Damian; Charles H Adler; Joseph G Hentz; Holly A Shill; John N Caviness; Marwan N Sabbagh; Virgilio G H Evidente; Thomas G Beach; Erika Driver-Dunckley
Journal:  Parkinsonism Relat Disord       Date:  2012-07-06       Impact factor: 4.891

3.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

Review 4.  Advances in Biomarker Research in Parkinson's Disease.

Authors:  Shyamal H Mehta; Charles H Adler
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

5.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

Review 6.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

7.  Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder.

Authors:  Carolina Gil-Tommee; Guadalupe Vidal-Martinez; C Annette Reyes; Javier Vargas-Medrano; Gloria V Herrera; Silver M Martin; Stephanie A Chaparro; Ruth G Perez
Journal:  Exp Neurol       Date:  2018-10-25       Impact factor: 5.330

8.  Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.

Authors:  Shinji Ito; Masaki Takao; Hiroyuki Hatsuta; Kazutomi Kanemaru; Tomio Arai; Yuko Saito; Masashi Fukayama; Shigeo Murayama
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

9.  Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control.

Authors:  Tessandra Stewart; Yu-Ting Sui; Luis F Gonzalez-Cuyar; David T W Wong; David M Akin; Vitor Tumas; Jan Aasly; Emily Ashmore; Patrick Aro; Carmen Ginghina; Ane Korff; Cyrus P Zabetian; James B Leverenz; Min Shi; Jing Zhang
Journal:  Neurobiol Aging       Date:  2013-09-13       Impact factor: 4.673

Review 10.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.